Compare WGS & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | ADUS |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2020 | 2009 |
| Metric | WGS | ADUS |
|---|---|---|
| Price | $45.89 | $122.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $82.00 | ★ $141.46 |
| AVG Volume (30 Days) | ★ 1.1M | 223.8K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.37 | 23.40 |
| EPS | N/A | ★ 4.39 |
| Revenue | ★ $427,539,000.00 | N/A |
| Revenue This Year | $11.40 | $7.09 |
| Revenue Next Year | $19.61 | $5.00 |
| P/E Ratio | ★ N/A | $27.61 |
| Revenue Growth | ★ 39.97 | N/A |
| 52 Week Low | $32.21 | $87.95 |
| 52 Week High | $170.87 | $131.59 |
| Indicator | WGS | ADUS |
|---|---|---|
| Relative Strength Index (RSI) | 33.81 | 51.12 |
| Support Level | $32.21 | $114.18 |
| Resistance Level | $72.65 | $131.59 |
| Average True Range (ATR) | 5.39 | 4.34 |
| MACD | -0.98 | -0.72 |
| Stochastic Oscillator | 4.82 | 31.20 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.